Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

2.06
Delayed Data
As of Mar 03
 +0.01 / +0.49%
Today’s Change
1.25
Today|||52-Week Range
5.68
+38.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues42.9M5.7M4.1M47.8M
 
 
 
 
 
Cost of Goods Sold0.00----7.9M
 
 
Depreciation And Amortization4.6M4.4M4.3M3.3M
 
 
 
 
 
 
Operating ExpensesGross Income38.3M----36.6M
 
 
 
General Expenses43.0M35.6M27.2M34.9M
 
 
 
 
 
Research And Development33.5M28.3M21.8M19.1M
 
 
 
 
 
Total Operating Expenses47.5M40.0M31.5M46.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.7M-34.4M-27.5M1.8M
 
 
 
 
 
Extraordinary Credit4.8M0.00479.0K0.00
 
 
 
Extraordinary Charge-79.0K-4.0M0.00-39.9M
 
 
 
 
Interest Expense On Debt1.6M2.2M1.4M1.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.5M-40.5M-28.0M-39.6M
 
 
 
 
 
Net Income-1.5M-40.5M-28.0M-39.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.5M6.8M12.5M16.7M
 
 
 
 
 
Shares To Calculate EPS Diluted5.5M6.8M12.5M16.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.30-$6.00-$2.24-$2.38
 
 
 
 
 
EPS Diluted-$0.30-$6.00-$2.24-$2.38
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account